Novartis copy of Amgen arthritis drug highly similar: FDA staff

July 11, 2016 3:37 PM

22 0

Novartis copy of Amgen arthritis drug highly similar: FDA staff

Novartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a review by Food and Drug Administration staff.

The review, posted on the FDA's website on Monday, comes two days ahead of a meeting of outside advisors who will discuss the drug and recommend whether it should be approved.

Read more

To category page

Loading...